Rv1105 Carboxylesterase, type B

Summary
Product Feature Type Start End Strand Length AA Length is TF
Rv1105 Carboxylesterase, type B CDS 1232311 1232826 + 516 171 FALSE

Rv1105 (Carboxylesterase, type B) is predicted to be co-regulated in modules bicluster_0270 with residual 0.54 and bicluster_0568 with residual 0.57.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 890.00 and 32,000.00 for bicluster_0270 and 68.00 and 380.00 for bicluster_0568 respectively.

These modules are enriched for following go terms: primary metabolic process, cellular metabolic process.

This gene is found to be for growth on cholesterol.

Mutant available?:

BASS Score Re-Annotated Start Tuberculist Annotated Start
-0.395 1232476 1232311
Product (LegacyBRC) Product (RefSeq)
POSSIBLE PARA-NITROBENZYL ESTERASE
Operon # Operon
747
PATRIC Locus Tag Enzyme Name PATRIC Pathways Transcriptomics

PATRIC

Not assigned Not assigned
Locus Tuberculist Genome View

Tuberculist

Quickview
Locus Tag KEGG Pathways

KEGG

Bisphenol degradation

35
Total items in this category:  

KEGG

Aminobenzoate degradation

73
Total items in this category:  

KEGG

Microbial metabolism in diverse environments

296
Total items in this category:  
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network

STRING

GI Number Protein ID Blast Conserved Domains
57116828 NP_215621.2 Run
No TFOE experiment results were found
Quantitative Proteomics Data
t-test p-value Cholesterol/Glycerol Ratio
0.160000 1.02

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: